Probiotic

IFF to Highlight Comprehensive Clean-label Portfolio at Vitafoods Europe 2024

Retrieved on: 
星期四, 五月 2, 2024
Lead, Digestion, E90, Tablet, Menopause, Dietary supplement, Health, OTC, Science, PRM, Probiotic, All rights reserved, Ageing, Food, Metabolism, Marketing, Creativity, Capsule

NEW YORK, May 2, 2024 /PRNewswire/ -- IFF, a global leader in food and beverage, home and personal care and health, will introduce its full suite of plant-based and cellulosic-derived solutions for dietary supplements and over-the-counter (OTC) drugs at Vitafoods Europe 2024. This is the first time IFF Pharma Solutions will showcase its full clean-label portfolio for oral dosage forms at Vitafoods Europe, May 14-16, Geneva, Switzerland, booth E90.

Key Points: 
  • This is the first time IFF Pharma Solutions will showcase its full clean-label portfolio for oral dosage forms at Vitafoods Europe, May 14-16, Geneva, Switzerland, booth E90.
  • "Our plant-based ingredients are meeting the rising demand for clean-label products," said Dr. Michael Baumann, marketing manager, Pharma Solutions, IFF.
  • Visit here to learn more about IFF Health and register here to schedule a meeting with IFF's Pharma Solutions experts.
  • IFF, the IFF Logo, and all trademarks and service marks denoted with ™, ℠ or ® are owned by IFF or affiliates of IFF unless otherwise noted.

Global Functional Dyspepsia Drug Market to reach a valuation of US$ 16.4 billion by 2034, Future Market Insights, Inc. Projection

Retrieved on: 
星期三, 五月 1, 2024
Gastroenterology, Transplant, Acupuncture, Indigestion, Research, Laboratory, Probiotic, Abbott Laboratories, Herbal, Therapy, Patient, Tissue engineering, Enzyme inhibitor, Regenerative medicine, Collaboration, Market, Diagnosis, Antacid, Drug development, Regeneration, Ageing, Investment, Nutritional science, Pharmaceutical industry

NEWARK, Del., May 1, 2024 /PRNewswire/ -- The global functional dyspepsia drug market will reach a valuation of US$ 10.3 billion in 2024, attributed to factors such as increasing geriatric population. The trend is set to create new opportunities for the market, leading to a projected CAGR of 4.8% between 2024 and 2034, and reaching a total valuation of approximately US$ 16.4 billion by 2034.

Key Points: 
  • NEWARK, Del., May 1, 2024 /PRNewswire/ -- The global functional dyspepsia drug market will reach a valuation of US$ 10.3 billion in 2024, attributed to factors such as increasing geriatric population.
  • Collaboration between pharmaceutical companies, academic institutions, and research organizations fosters innovation in functional dyspepsia drug development.
  • Key Takeaways from the Market Study:
    Global functional dyspepsia drug market was valued at US$ 9.7 billion in 2023.
  • The functional dyspepsia drug market is characterized by a diverse array of pharmaceutical companies, research institutions, and healthcare organizations striving to develop and commercialize innovative treatments for functional dyspepsia.

Global Functional Dyspepsia Drug Market to reach a valuation of US$ 16.4 billion by 2034, Future Market Insights, Inc. Projection

Retrieved on: 
星期三, 五月 1, 2024
Gastroenterology, Transplant, Acupuncture, Indigestion, Research, Laboratory, Probiotic, Abbott Laboratories, Herbal, Therapy, Patient, Tissue engineering, Enzyme inhibitor, Regenerative medicine, Collaboration, Market, Diagnosis, Antacid, Drug development, Regeneration, Ageing, Investment, Nutritional science, Pharmaceutical industry

NEWARK, Del., May 1, 2024 /PRNewswire/ -- The global functional dyspepsia drug market will reach a valuation of US$ 10.3 billion in 2024, attributed to factors such as increasing geriatric population. The trend is set to create new opportunities for the market, leading to a projected CAGR of 4.8% between 2024 and 2034, and reaching a total valuation of approximately US$ 16.4 billion by 2034.

Key Points: 
  • NEWARK, Del., May 1, 2024 /PRNewswire/ -- The global functional dyspepsia drug market will reach a valuation of US$ 10.3 billion in 2024, attributed to factors such as increasing geriatric population.
  • Collaboration between pharmaceutical companies, academic institutions, and research organizations fosters innovation in functional dyspepsia drug development.
  • Key Takeaways from the Market Study:
    Global functional dyspepsia drug market was valued at US$ 9.7 billion in 2023.
  • The functional dyspepsia drug market is characterized by a diverse array of pharmaceutical companies, research institutions, and healthcare organizations striving to develop and commercialize innovative treatments for functional dyspepsia.

NBPure Launches Clean, Gut-Nourishing, Family-Friendly Electrolyte Drink Mix With Influencer @EarthyAndy

Retrieved on: 
星期三, 五月 1, 2024
Calcium, Magnesium, Health, GMO, Partnership, Electrolyte, Water, Methyl group, Potassium, Sodium, Probiotic, B-12, Absorption, Inulin, Nutritional science

The product, Earthy Andy Hawaiian Hydration, is a clean, gut-nourishing, family-friendly, electrolyte hydration drink mix for health-minded adults and kids.

Key Points: 
  • The product, Earthy Andy Hawaiian Hydration, is a clean, gut-nourishing, family-friendly, electrolyte hydration drink mix for health-minded adults and kids.
  • Earthy Andy Hawaiian Hydration is made with natural ingredients and contains no sugar or artificial flavors, dyes, or sweeteners.
  • Andrea Hannemann, a mother of four children ages 1 to 15, is passionate about maintaining her family's health and wellness.
  • "Our new Hawaiian Hydration electrolyte drink mix is pure and good for you, and it tastes amazing thanks to the natural whole food flavors we mix in."

Chrissy Teigen and John Legend Expand Their Love For Dogs With Kismet

Retrieved on: 
星期三, 五月 1, 2024
Dog, CNN Heroes, Pet, Mineral, Love, Legend, Parent, CNN, Life, Probiotic, Food, Medicine, LOS, Rehabilitation, Food preservation

LOS ANGELES, May 1, 2024 /PRNewswire/ -- Entrepreneurs Chrissy Teigen and John Legend announce their first-ever joint business venture with the launch of Kismet, a pet lifestyle brand offering premium quality food for dogs, merchandise, and content for today's modern dog families.

Key Points: 
  • LOS ANGELES, May 1, 2024 /PRNewswire/ -- Entrepreneurs Chrissy Teigen and John Legend announce their first-ever joint business venture with the launch of Kismet, a pet lifestyle brand offering premium quality food for dogs, merchandise, and content for today's modern dog families.
  • In a word, it's Kismet," said co-founders Chrissy Teigen and John Legend.
  • "It has been a joy to work alongside Chrissy and John to establish Kismet.
  • As a brand, we want to bring people together with a shared love of dogs who are ready for something fresh in this category.

GT's Living Foods Launches First-Ever Fan-Created Innovation

Retrieved on: 
星期三, 五月 1, 2024
Sprouts, Target, Walmart, Social media, Social media marketing, Marketing, Probiotic, Metabolism, LOS, Immunity, Soft drink

LOS ANGELES, May 1, 2024 /PRNewswire/ -- Today, GT's Living Foods (GT's), the maker of the first-ever bottled kombucha to be sold in the United States, is announcing its first-ever fan-created product, SYNERGY® Pomelo Pink Lemonade Raw Kombucha. The new item was submitted and voted by the brand's social media followers via an interactive flavor contest. The social media campaign garnered more than 17,000 flavor submissions which resulted in three top innovation options for followers to vote for: Tropical Colada, Cherry Hibiscus and the contest winner, Pomelo Pink Lemonade, which earned the most votes from the total 25,000+ votes casted.

Key Points: 
  • The new item was submitted and voted by the brand's social media followers via an interactive flavor contest.
  • "SYNERGY® Pomelo Pink Lemonade Raw Kombucha is a love letter to our community.
  • SYNERGY® Pomelo Pink Lemonade Raw Kombucha can be found at all retailers nationwide including Target, Walmart, Sprouts, H.E.B., and Publix stores.
  • To learn more about GT's Living Foods and SYNERGY® Raw Kombucha visit www.gtslivingfoods.com .

MD Logic Health® Introduces Their New Low Molecular Bioactive Colostrum

Retrieved on: 
星期二, 四月 30, 2024
Sale, Digestion, Protein, Solubility, Pinnacle, Milk, Cytokine, MD, Logic, Probiotic, Peptide, Colostrum, Immunity, Absorption, Nutritional science, Fats, Dairy

MIAMI, April 30, 2024 /PRNewswire-PRWeb/ -- In an era where gut health is paramount, MD Logic Health® has once again raised the bar with the introduction of its Low Molecular Bioactive Colostrum), a new pinnacle in health supplements for superior gut health and overall well-being. Known for their unwavering dedication to excellence and innovation, MD Logic Health®'s latest formulation offers unparalleled potency, purity, and efficacy.

Key Points: 
  • MD Logic Health® raises the bar in gut health innovation with its new Low Molecular Bioactive Colostrum, offering unmatched potency and efficacy.
  • - Wesley Ramjeet, CEO of MD Logic Health®
    As the market's demand for effective gut health solutions intensifies, MD Logic Health® delivers a compelling answer with its Low Molecular Bioactive Colostrum.
  • The Low Molecular Bioactive Colostrum is sourced from all-natural, hormone-free grass-fed cattle maintained on a carefully selected, nutrient-rich diet.
  • MD Logic Health®'s Low Molecular Bioactive Colostrum is a revolution in wellness, designed to meet the needs of modern health-conscious consumers.

Probiotics in Animal Feed Market Size to Grow USD 5357.7 Million by 2030 at a CAGR of 4.2% | Valuates Reports

Retrieved on: 
星期一, 四月 29, 2024
USD, Dietary supplement, Health, Animal, Probiotic, Poultry, Growth, Farmer, Cattle, Environment, Livestock

The Global Probiotics in Animal Feed Market was valued at USD 3897.4 Million in 2023 and is anticipated to reach USD 5357.7 Million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.

Key Points: 
  • The Global Probiotics in Animal Feed Market was valued at USD 3897.4 Million in 2023 and is anticipated to reach USD 5357.7 Million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
  • TRENDS INFLUENCING THE GROWTH OF PROBIOTICS IN ANIMAL FEED MARKET:
    Probiotics are becoming more and more prevalent in animal feed as a result of the industry's move towards sustainable and natural options.
  • https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-18H10252...
    PROBIOTICS IN ANIMAL FEED MARKET SHARE ANALYSIS:
    Due to its vast livestock base, high meat consumption, and rising consumer knowledge of the benefits of probiotics for animal health, Asia-Pacific held the greatest market share for probiotics in animal feed in 2017.
  • The probiotics market for animal feed is anticipated to increase as a result of the region's rapidly expanding dairy and meat sectors.

Probiotics in Animal Feed Market Size to Grow USD 5357.7 Million by 2030 at a CAGR of 4.2% | Valuates Reports

Retrieved on: 
星期一, 四月 29, 2024
USD, Dietary supplement, Health, Animal, Probiotic, Poultry, Growth, Farmer, Cattle, Environment, Livestock

The Global Probiotics in Animal Feed Market was valued at USD 3897.4 Million in 2023 and is anticipated to reach USD 5357.7 Million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.

Key Points: 
  • The Global Probiotics in Animal Feed Market was valued at USD 3897.4 Million in 2023 and is anticipated to reach USD 5357.7 Million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
  • TRENDS INFLUENCING THE GROWTH OF PROBIOTICS IN ANIMAL FEED MARKET:
    Probiotics are becoming more and more prevalent in animal feed as a result of the industry's move towards sustainable and natural options.
  • https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-18H10252...
    PROBIOTICS IN ANIMAL FEED MARKET SHARE ANALYSIS:
    Due to its vast livestock base, high meat consumption, and rising consumer knowledge of the benefits of probiotics for animal health, Asia-Pacific held the greatest market share for probiotics in animal feed in 2017.
  • The probiotics market for animal feed is anticipated to increase as a result of the region's rapidly expanding dairy and meat sectors.

Nearly 90% of Pet Parents Willing to Adjust Budgets to Afford Pets' Expenses, Per New Acosta Group Study

Retrieved on: 
星期一, 四月 29, 2024
Social media, Pet, Health, Thought, Parent, Research, Habit, Cat, SVP, Family, Probiotic, Food, Medicine, Dog, National Pet Month, Pet industry

JACKSONVILLE, Fla., April 29, 2024 /PRNewswire/ -- As National Pet Month kicks off on May 1, Acosta Group is releasing a new study conducted with its proprietary Shopper Community highlighting pet parents' shopping habits. With two in three U.S. households owning at least one dog or cat, shopping for food, treats, and health care needs for pets has become a significant part of household budgets. According to the study's findings, 96% of pet parents consider their pets part of the family, and 86% are willing to adjust their budgets to afford their pets' expenses, reflecting a valuable opportunity for retailers and brands to prioritize this audience.

Key Points: 
  • "Our study validates the deep bonds people establish with their pets as true members of their families.
  • These connections drive informed decisions on the ongoing purchases made throughout their pets' lives," said Kathy Risch , SVP, Thought Leadership and Shopper Insights, Acosta Group.
  • According to Acosta Group data, most pet owners are turning to mass retailers, pet specialty stores and online retailers for their pet care purchases.
  • Acosta Group's Pet Ownership Shopper Insights Study was conducted from Jan. 11-17, 2024, with 1,137 primary household shoppers who own dogs and cats ages 18+.